Successful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case report.

Takao M, Inoue K, Watanabe F, Onoda K, Shimono T, Shimpo H, Yada I.

World J Surg Oncol. 2003 Jul 1;1(1):8.

PMID: 12917017 [PubMed - as supplied by publisher]

Related Articles Free article in PMC

Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports.

Kitazaki T, Fukuda M, Soda H, Kohno S.

Lung Cancer. 2005 Jul;49(1):125-8.

PMID: 15949598 [PubMed - indexed for MEDLINE]

Related Articles

Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa).

Milton DT, Kris MG, Gomez JE, Feinstein MB.

Support Care Cancer. 2005 Jan;13(1):70-2. Epub 2004 Nov 19.

PMID: 15558327 [PubMed - indexed for MEDLINE]

Related Articles

Successful treatment of multifocal bronchioloalveolar cell carcinoma with ZD1839 (Iressa) in two patients.

Chang GC, Yang TY, Wang NS, Huang CM, Chiang CD.

J Formos Med Assoc. 2003 Jun;102(6):407-11.

PMID: 12923594 [PubMed - indexed for MEDLINE]

Related Articles

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.

Cohen MH, Williams GA, Sridhara R, Chen G, McGuinn WD Jr, Morse D, Abraham S, Rahman A, Liang C, Lostritto R, Baird A, Pazdur R.

Clin Cancer Res. 2004 Feb 15;10(4):1212-8.

PMID: 14977817 [PubMed - indexed for MEDLINE]

Related Articles

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.

Kijima T, Suzuki M, Ueda K, Minami S, Takeda Y, Goya S, Matsuoka H, Kumagai T, Yoshida M, Osaki T, Tachibana I, Yokota S, Kawase I.

Oncol Res. 2007;16(10):489-95.

PMID: 18196873 [PubMed - indexed for MEDLINE]

Related Articles

Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma.

Homma S, Kawabata M, Kishi K, Tsuboi E, Narui K, Nakatani T, Nakata K.

Chest. 1999 May;115(5):1465-8.

PMID: 10334175 [PubMed - indexed for MEDLINE]

Related Articles

[Efficacy of gefitinib (Iressa) in the treatment of an inoperable bronchioloalveolar cell carcinoma]

Bayle S, Descourt R, Gouva S, Daniel C, Robinet G.

Rev Mal Respir. 2004 Feb;21(1):153-7. French.

PMID: 15260051 [PubMed - indexed for MEDLINE]

Related Articles

Gefitinib ('Iressa', ZD1839) is active against brain metastases in a 77 year old patient.

Roggero E, Busi G, Palumbo A, Pedrazzini A.

J Neurooncol. 2005 Feb;71(3):277-80. Erratum in: J Neurooncol. 2005 Sep;74(2):221. Giancarla, Busi [corrected to Busi, Giancarla]; Antonella, Palumbo [corrected to Palumbo, Antonella]; Augusto, Pedrazzini [corrected to Pedrazzini, Augusto].

PMID: 15735917 [PubMed - indexed for MEDLINE]

Related Articles

Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.

Argiris A, Mittal N.

Lung Cancer. 2004 Mar;43(3):317-22.

PMID: 15165090 [PubMed - indexed for MEDLINE]

Related Articles

Clinically meaningful response to the EGFR tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in non small cell lung cancer.

Gelibter A, Ceribelli A, Milella M, Mottolese M, Vocaturo A, Cognetti F.

J Exp Clin Cancer Res. 2003 Sep;22(3):481-5.

PMID: 14582710 [PubMed - indexed for MEDLINE]

Related Articles

Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer.

Araki J, Okamoto I, Suto R, Ichikawa Y, Sasaki J.

Lung Cancer. 2005 Apr;48(1):141-4. Epub 2004 Dec 9.

PMID: 15777982 [PubMed - indexed for MEDLINE]

Related Articles

Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study.

Schilder RJ, Sill MW, Chen X, Darcy KM, Decesare SL, Lewandowski G, Lee RB, Arciero CA, Wu H, Godwin AK.

Clin Cancer Res. 2005 Aug 1;11(15):5539-48.

PMID: 16061871 [PubMed - indexed for MEDLINE]

Related Articles

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ.

BMC Cancer. 2004 Aug 19;4:51.

PMID: 15318946 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Gefitinib (Iressa, ZD1839): a novel targeted approach for the treatment of solid tumors.

Von Pawel J.

Bull Cancer. 2004 May 1;91(5):E70-6. Review.

PMID: 15582898 [PubMed - indexed for MEDLINE]

Related Articles

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM.

Cancer Res. 2004 Aug 1;64(15):5355-62.

PMID: 15289342 [PubMed - indexed for MEDLINE]

Related Articles

Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells.

Kitazaki T, Soda H, Doi S, Nakano H, Nakamura Y, Kohno S.

Lung Cancer. 2005 Oct;50(1):19-24.

PMID: 16009452 [PubMed - indexed for MEDLINE]

Related Articles

Long-term effect of gefitinib (ZD1839) on squamous cell carcinoma of the lung.

Kozuki T, Kiura K, Ueoka H, Tabata M, Date H, Hamazaki S, Bessho A, Tanimoto M.

Anticancer Res. 2004 Jan-Feb;24(1):393-6.

PMID: 15015626 [PubMed - indexed for MEDLINE]

Related Articles

Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.

Razis E, Skarlos D, Briasoulis E, Dimopoulos M, Fountzilas G, Lambropoulos S, Rigatos S, Kopterides P, Efstathiou H, Tzamakou E, Bakoyannis C, Pectasides D, Makatsoris T, Varthalitis G, Papadopoulos S, Kosmidis P.

Anticancer Drugs. 2005 Feb;16(2):191-8.

PMID: 15655417 [PubMed - indexed for MEDLINE]

Related Articles

Successful treatment of hypertrophic osteoarthropathy by gefitinib in a case with lung adenocarcinoma.

Hayashi M, Sekikawa A, Saijo A, Takada W, Yamawaki I, Ohkawa S.

Anticancer Res. 2005 May-Jun;25(3c):2435-8.

PMID: 16080471 [PubMed - indexed for MEDLINE]

Related Articles